Skip to content

Comparison of amniotic membrane and phenytoin cream on the size of ulcer in pressure ulcer sore, Clinical trial phase 2

Using of amniotic membrane and phenytoin cream on the size of ulcer in the patients with pressure ulcer, clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201612041335N2
Enrollment
30
Registered
2017-03-07
Start date
2013-12-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pressure ulcer. Pressure ulcer of unspecified site, unspecified stage

Interventions

Intervention 1: In the control group, phenytoin cream is used for covering of ulcer. In this group after washing, phenytoin cream that contains ten gram phenytoin and one gram vaselin is prepared and
Treatment - Drugs
In the control group, phenytoin cream is used for covering of ulcer. In this group after washing, phenytoin cream that contains ten gram phenytoin and one gram vaselin is prepared and applied on the u
In the amnion group, amniotic membrane is used for covering of ulcer. In this group after washing, an amniotic membrane is applied and dressing is done. Dressing is changed every two to three days unt

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: age more than 18 years; pressure ulcer grade two or three; lack of infection Exclusion criteria: presence of malignancy at site of ulcer; ulcer grade one or four; pregnant or lactating woman

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Size of ulcer. Timepoint: Daily. Method of measurement: Ruler.

Secondary

MeasureTime frame
Infection. Timepoint: daily. Method of measurement: wound discharge.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegar Azarpira

Shiraz university of Medical Sciences

azarpiran@sums.ac.ir+98 71 3647 3954

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 8, 2026